acetaminophen, aspirin and caffeine
Generic: acetaminophen, aspirin and caffeine
Labeler: rising pharma holdings, inc.Drug Facts
Product Profile
Brand Name
acetaminophen, aspirin and caffeine
Generic Name
acetaminophen, aspirin and caffeine
Labeler
rising pharma holdings, inc.
Dosage Form
TABLET
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
57237-348
Product ID
57237-348_607f9cfd-3a13-4597-b7e9-70a3377fc1d6
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2025-07-09
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57237348
Hyphenated Format
57237-348
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acetaminophen, aspirin and caffeine (source: ndc)
Generic Name
acetaminophen, aspirin and caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (57237-348-01)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "607f9cfd-3a13-4597-b7e9-70a3377fc1d6", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["50f72713-50f5-4bab-9e96-b9fa73c9df1f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (57237-348-01)", "package_ndc": "57237-348-01", "marketing_start_date": "20250709"}], "brand_name": "Acetaminophen, Aspirin and Caffeine", "product_id": "57237-348_607f9cfd-3a13-4597-b7e9-70a3377fc1d6", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "57237-348", "generic_name": "Acetaminophen, Aspirin and Caffeine", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Acetaminophen, Aspirin and Caffeine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250709", "listing_expiration_date": "20261231"}